< back to search

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial.

Braun, J   •   Brandt, J   •   Listing, J   •   Zink, A   •   Alten, R   •   Golder, W   •   Gromnica-Ihle, E   •   Kellner, H   •   Krause, A   •   Schneider, M   •   Sorensen, H   •   Zeidler, H   •   Thriene, W   •   Sieper, J

published in: Lancet (London, England)



endpoint

Infliximab has (optional: compared with placebo) proved to be better.
complication rate higher


basics

diagnosis:
ankylosing spondylitis

localization:
not specified

method:
conservative therapy → injection therapy
conservative therapy → injection

publication details

10.1016/s0140-6736(02)08215-6
pubmed
11955536
2002
journal
randomized controlled trial
yes
prospective
1+

▼
▲